PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and the University of Oulu, Finland.
Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki and Oulu, Finland.
PLoS One. 2020 Mar 5;15(3):e0229496. doi: 10.1371/journal.pone.0229496. eCollection 2020.
To assess the frequency and perinatal outcomes of gestational diabetes mellitus (GDM) defined by the criteria according to the International Association of Diabetes in Pregnancy Study Group (IADPSG) and the National Institute for Health and Care Excellence (NICE) diagnostic criteria for GDM.
A retrospective cohort study.
Six secondary and tertiary delivery hospitals in Finland in 2009.
Pregnant women (N = 4,033) and their offspring.
We used data on comprehensive screening of pregnant women with a 2-h 75-g oral glucose tolerance test (OGTT), performed between gestational weeks 24 and 40. OGTT glucose concentrations were used to identify women who fulfilled IADPSG and NICE criteria. While cut-offs according to Finnish national criteria partly overlapped with both criteria, a subgroup of IADPSG- or NICE-positive GDM women remained undiagnosed by Finnish criteria and hence non-treated. They were analysed as subgroups and compared to controls who were negative with all cut-offs.
GDM prevalence, birth weight SD score (BWSDS), large for gestational age (LGA) and caesarean section (CS) rates.
Among the 4,033 women screened for GDM, 1,249 (31.0%) and 529 (13.1%) had GDM according to the IADPSG and NICE criteria, respectively. The LGA rate was similar in both groups. Regardless of the diagnostic criteria, women with GDM had a higher risk of induced delivery and CSs than controls. In IADPSG-positive non-treated women, offspring's BWSDS and CS rate were higher than in controls.
GDM prevalence was 2.4-fold higher according to the IADPSG compared with the NICE criteria but the LGA rate did not differ. BWSDS and CS rate were increased already with mild untreated hyperglycaemia.
评估根据国际妊娠糖尿病研究组(IADPSG)和英国国家卫生与临床优化研究所(NICE)的 GDM 诊断标准定义的妊娠期糖尿病(GDM)的频率和围产结局。
回顾性队列研究。
芬兰六家二级和三级分娩医院,于 2009 年开展。
孕妇(N=4033)及其后代。
我们使用了在妊娠 24 至 40 周期间进行的 2 小时 75 克口服葡萄糖耐量试验(OGTT)全面筛查孕妇的数据。OGTT 葡萄糖浓度用于确定符合 IADPSG 和 NICE 标准的女性。虽然芬兰国家标准的切点与两种标准部分重叠,但部分 IADPSG 或 NICE 阳性 GDM 妇女仍未被芬兰标准诊断为未治疗的 GDM。将其作为亚组进行分析,并与所有切点均为阴性的对照组进行比较。
GDM 患病率、出生体重标准差评分(BWSDS)、巨大儿(LGA)和剖宫产(CS)率。
在筛查 GDM 的 4033 名女性中,根据 IADPSG 和 NICE 标准,分别有 1249 名(31.0%)和 529 名(13.1%)患有 GDM。两组的 LGA 发生率相似。无论诊断标准如何,患有 GDM 的女性与对照组相比,引产和 CS 的风险更高。在 IADPSG 阳性未治疗的女性中,其后代的 BWSDS 和 CS 率高于对照组。
与 NICE 标准相比,根据 IADPSG 标准,GDM 的患病率增加了两倍,但 LGA 率没有差异。即使是轻度未治疗的高血糖,也会增加 BWSDS 和 CS 率。